Abstract
A critical appraisal and clinical application of Krause DS, Simjee AE, van Rensburg C, et al. A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clin Infect Dis. 2004;39(6):770-775. doi: 10.1086/423378.
DOI
10.22237/crp/1535500980
Recommended Citation
SANFORD BS. Anidulafungin: a noninferior alternative to fluconazole for treatment of esophageal candidiasis. Clin. Res. Prac. 2018 Aug 30;4(1):eP1727. doi: 10.22237/crp/1535500980
Included in
Infectious Disease Commons, Internal Medicine Commons, Medical Education Commons, Translational Medical Research Commons